Active substance
Results for the substance abatacept
3 results
About this active substance
Abatacept is a medication used to treat autoimmune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. It is a biologic agent that works by inhibiting T-cell activation, thereby reducing inflammation and the abnormal immune response underlying these conditions.
Abatacept is administered either as a subcutaneous injection or an intravenous infusion, as directed by a healthcare provider. It is typically used in patients who have not responded adequately to other therapies, such as methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
Side effects may include respiratory infections, headaches, nausea, or injection site reactions. Since abatacept can increase the risk of infections, patients should be closely monitored, and its use is contraindicated in cases of severe active infections.
This medication is effective in reducing symptoms and slowing disease progression but requires long-term administration and regular monitoring to assess its efficacy and safety.
Abatacept is administered either as a subcutaneous injection or an intravenous infusion, as directed by a healthcare provider. It is typically used in patients who have not responded adequately to other therapies, such as methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
Side effects may include respiratory infections, headaches, nausea, or injection site reactions. Since abatacept can increase the risk of infections, patients should be closely monitored, and its use is contraindicated in cases of severe active infections.
This medication is effective in reducing symptoms and slowing disease progression but requires long-term administration and regular monitoring to assess its efficacy and safety.